glp-1 support group SoWell (Dr. Alexandra Sowa) Everyone’s got an opinion on

Confirm the prescribing provider conducts a clinical evaluation and reviews contraindications

Starving yourself will not work with this protocol

Approximately 25% of the weight lost on tirzepatide was lean mass rather than fat, and in semaglutide trials (STEP 1 DXA subset), that proportion may approach 40%

In both procedures examined, surgical volume and corresponding medication showed inverse growth trajectories in recent years

It is important to note that no randomized trial has included a head-to-toe comparison between these two drugs, to evaluate their relative roles in preventing kidney failure and death among patients with diabetes and CKD, especially in patients with varying baseline kidney function, albuminuria severity, and comorbidities such as cardiovascular disease or obesity. Read More About Kidney Disease Management of kidney disease is vital to overall health and quality of life

Tirzepatide follows a weekly dosing schedule, and dose increases typically happen every four weeks during titration